Identification and refinement of a peptide affinity ligand with unique specificity for a monoclonal anti-tenascin-C antibody by screening of a phage display library

被引:12
作者
Bellofiore, P
Petronzelli, F
De Martino, T
Minenkova, O
Bombardi, V
Anastasi, AM
Lindstedt, R
Felici, F
De Santis, R
Verdoliva, A
机构
[1] Tecnogen SCpA, I-81015 Piana Monte Verna, CE, Italy
[2] Sigma Tau SpA R&D, I-00040 Rome, Italy
[3] Sigma Tau Pharmaceut Co, Kenton Labs, Rome, Italy
关键词
affinity purification; monoclonal antibody; phage display technology; PAGRIT; host cell proteins;
D O I
10.1016/j.chroma.2005.12.064
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Using phage display technology, a 22-mer peptide was selected as a ligand with unique specificity for the murine monoclonal ST2146 antibody that recognizes the EGF repeats region of the human tumor-associated antigen tenascin-C. This peptide, synthesized in an 8-branched form to enhance its binding properties, is useful in replacing the native antigen in the affinity and immunoreactivity characterization of the ST2146 antibody and its biotinylated derivatives. Affinity resins, prepared by immobilizing the mimotope or its shorter 10-mer binding unit on a chromatographic support, were able to capture ST2146 directly from the hybridoma supernatant, with antibody recovery and host cell protein (HCP) reduction similar to or better than protein A sorbent, a purity degree exceeding 95%, and full recovery of antibody activity. The affinity constants of both peptides, as determined by frontal analysis of broad-zone elution affinity chromatography and BiaCore measurements, were very similar and included in a range suitable for affinity ligands. Column capacity, determined by applying a large excess of purified ST2146 to I mL of column bed volume, was close to 50 mg/mL for both resins. These matrices retain their ST2146 binding properties after various treatments, including sanitization, thus indicating very high stability in terms of ligand leakage and degradation. Moreover, the short form shows higher enzymatic stability, thus proving more suitable as ligand for ST2146 affinity purification. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:182 / 191
页数:10
相关论文
共 49 条
[1]   PURIFICATION OF HEXABRACHION (TENASCIN) FROM CELL-CULTURE CONDITIONED MEDIUM, AND SEPARATION FROM A CELL-ADHESION FACTOR [J].
AUKHIL, I ;
SLEMP, CC ;
LIGHTNER, VA ;
NISHIMURA, K ;
BRISCOE, G ;
ERICKSON, HP .
MATRIX, 1990, 10 (02) :98-111
[2]   HIGH-AFFINITY RABBIT ANTIBODIES DIRECTED AGAINST METHOTREXATE - PRODUCTION, PURIFICATION, CHARACTERIZATION, AND PHARMACOKINETICS IN THE RAT [J].
BALTHASAR, JP ;
FUNG, HL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (01) :2-6
[3]   PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN TENASCIN [J].
BALZA, E ;
SIRI, A ;
PONASSI, M ;
CAOCCI, F ;
LINNALA, A ;
VIRTANEN, I ;
ZARDI, L .
FEBS LETTERS, 1993, 332 (1-2) :39-43
[4]   Identification of peptides that mimic the pertussis toxin binding site on bovine fetuin [J].
Bogdan, JA ;
Yuan, W ;
Long-Rowe, KO ;
Sarwar, J ;
Brucker, EA ;
Blake, MS .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2003, 69 (10) :6272-6279
[5]   The use of thiophilic chromatography for antibody purification: a review [J].
Boschetti, E .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2001, 49 (1-3) :361-389
[6]   SEPARATION OF IMMUNOGLOBULIN-G FROM HUMAN SERUM BY PSEUDOBIOAFFINITY CHROMATOGRAPHY USING IMMOBILIZED L-HISTIDINE IN HOLLOW-FIBER MEMBRANES [J].
BUENO, SMA ;
HAUPT, K ;
VIJAYALAKSHMI, MA .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 667 (01) :57-67
[7]   Monoclonal and polyclonal antibodies against human ferritin, a nonspecific turner marker [J].
Chou, SF ;
Chen, CY .
HYBRIDOMA, 2001, 20 (01) :59-62
[8]   Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients [J].
Cremonesi, M ;
Ferrari, M ;
Chinol, M ;
Stabin, MG ;
Grana, C ;
Prisco, G ;
Robertson, C ;
Tosi, G ;
Paganelli, G .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (02) :110-120
[9]   Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRITR) [J].
De Santis, R ;
Anastasi, AM ;
D'Alessio, V ;
Pelliccia, A ;
Albertoni, C ;
Rosi, A ;
Leoni, B ;
Lindstedt, R ;
Petronzelli, F ;
Dani, M ;
Verdoliva, A ;
Ippolito, A ;
Campanile, N ;
Manfredi, V ;
Esposito, A ;
Cassani, G ;
Chinol, M ;
Paganelli, G ;
Carminati, P .
BRITISH JOURNAL OF CANCER, 2003, 88 (07) :996-1003
[10]   MONOCLONAL-ANTIBODIES THAT RECOGNIZE FILAMENTOUS PHAGE - TOOLS FOR PHAGE DISPLAY TECHNOLOGY [J].
DENTE, L ;
CESARENI, G ;
MICHELI, G ;
FELICI, F ;
FOLGORI, A ;
LUZZAGO, A ;
MONACI, P ;
NICOSIA, A ;
DELMASTRO, P .
GENE, 1994, 148 (01) :7-13